Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Sulfonamides; Indazoles; Pyrimidines; Angiogenesis Inhibitors; Disease-Free Survival; Double-Blind Method; Adult; Aged; Aged, 80 and over
- PubMed ID
- 38531002
- PubMed Central ID
- PMC11514296
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked